Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1513

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 6
Chunk 1513
---
’s outside auditor, and who worked on the company’s audit.

Under such definitions, our Board has undertaken
a review of the independence of each director and director nominee. Based on information provided by each director concerning his or
her background, employment and affiliations, our Board has determined that Charles Allen, Stephen Toovey and Paul Field, are independent
directors of the Company.

Committees of the Board of Directors

Our Board has three standing committees: (i)
an audit committee (the “Audit Committee”); (ii) a compensation committee (the “Compensation Committee”); and
(iii) a nominating and corporate governance committee (the “Nominating and Corporate Governance Committee”). Our Board has
not yet adopted procedures by which stockholders may recommend nominees to the Board. The composition and responsibilities of each of
the committees of our Board are described below. Members serve on these committees until their resignation or until as otherwise determined
by our Board.

Audit Committee

We have established the Audit Committee consisting
of Charles Allen, who is the Chairman of the Audit Committee, Stephen Toovey and Paul Field. Charles Allen qualifies as an audit committee
financial expert within the meaning of Item 407(d) of Regulation S-K under the Securities Act. Our Board adopted an Audit Committee Charter
on March 16, 2023, of which was deemed effective as of July 11, 2023. The Audit Committee’s duties, which are specified in our
Audit Committee Charter, include, but are not limited to:

●reviewing
                                            and discussing with management and the independent auditor the annual audited financial statements,
                                            and recommending to the board whether the audited financial statements should be included
                                            in our annual disclosure report;

●discussing
                                            with management and the independent auditor significant financial reporting issues and judgments
                                            made in connection with the preparation of our financial statements;

●discussing
                                            with management major risk assessment and risk management policies;

●monitoring
                                            the independence of the independent auditor;

●verifying
                                            the rotation of the lead (or coordinating) audit partner having primary responsibility for
                                            the audit and the audit partner responsible for reviewing the audit as required by law;

●reviewing
                                            and approving all related-party transactions;

●inquiring
                                            and discussing with management our compliance with applicable laws and regulations;

●pre-approving
                                            all audit services and permitted non-audit services to be performed by our independent auditor,
                                            including the fees and terms